• Digoxin: Applied Cardiac and Antiviral Workflows

  2026-08-19

  Digoxin connects Na+/K+ ATPase inhibition with practical studies of cardiac contractility, arrhythmia biology, heart failure, and cell-specific chikungunya virus responses. This guide turns the product dossier into reproducible workflows, dose-selection logic, and troubleshooting checkpoints while separating established findings from assay-development recommendations.

• Topotecan HCl and the Logic of DNA Damage Selectivity

  2026-08-19

  Topotecan HCl offers a mechanistically precise way to study how DNA damage burden, replication stress, and repair capacity shape tumor response. This thought-leadership guide connects topoisomerase I-DNA complex stabilization with translational oncology strategy, while using recent neuroinflammation findings to sharpen—not overextend—the framework for selective vulnerability.

• Phenytoin and Human PON1: Noncompetitive Inhibition

  2026-08-18

  Beydemir and Demir examined how five antiepileptic drugs inhibit human serum paraoxonase-1 (hPON1) in vitro, combining enzyme purification with concentration-response and kinetic analyses. Phenytoin inhibited hPON1 less strongly than gabapentin, valproic acid, and primidone but more strongly than levetiracetam, while all five compounds showed noncompetitive inhibition under the study conditions.

• Genetically Engineered Mouse Models of Mesothelioma

  2026-08-18

  Kadariya and colleagues present a protocol-centered framework for modeling malignant mesothelioma with genetically engineered mice, linking Bap1, Cdkn2a/b, and Nf2 tumor-suppressor biology to asbestos exposure, inflammation, and therapeutic testing. The review’s main practical contribution is the organization of germline, knock-in, asbestos-induced, and conditional knockout models into experimentally useful workflows that preserve an immunocompetent tumor microenvironment.

• Silymarin and Silybin A Metabolic Workflows

  2026-08-17

  Build reproducible liver and adipocyte assays with purified Silybin A, emphasizing solvent control, dose-response design, and orthogonal metabolic readouts. A CRISPRi obesity study provides a practical framework for pairing adipose-targeted gene silencing with independent biochemical interventions while keeping causal claims appropriately bounded.

• Anti-Diabetic Drugs and Weight Loss in Type 2 Diabetes

  2026-08-17

  This 2021 Pharmacological Research review organizes non-insulin glucose-lowering therapies by their observed effects on body weight, BMI, and body composition in type 2 diabetes. Its clinically useful contribution is a comparative framework that places ertugliflozin among agents associated with moderate weight loss while distinguishing this effect from the stronger reductions reported for selected GLP-1 receptor agonists and tirzepatide.

• Regorafenib (BAY 73-4506) Research Guide

  2026-08-16

  Regorafenib, also called BAY 73-4506, is an orally active multikinase inhibitor for studying angiogenesis, oncogenic signaling, and tumor progression. Product data and a 2024 iScience study support its use in kinase assays, tumor xenograft models, and melanoma mechanism studies, while model-specific limits remain important.

• Balsalazide Disodium: UC Research Workflows

  2026-08-15

  Balsalazide disodium supports practical ulcerative colitis research, from soluble in vitro inflammation assays to colon-focused animal studies and radiotracer development. Its bacterial azoreductase activation and reference-backed radioiodination workflow help researchers connect compound exposure with localized disease biology.

• α-Linolenic Acid: Designing Causal Lipid Assays

  2026-08-15

  α-Linolenic Acid (ALA) is more than an omega-3 substrate: it is a controllable probe for lipid flux, membrane remodeling, and signaling. This guide translates recent arachidonic acid–immunity findings into rigorous assay-design principles while defining what ALA experiments can—and cannot—demonstrate.

• Central Circuits of Opioid Mechanical Hypersensitivity

  2026-08-14

  Yin et al. identify a lateral parabrachial nucleus–hypothalamus–spinal cord pathway that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study shows that selective central MOR activation can paradoxically promote mechanical pain hypersensitivity, providing a circuit framework for opioid receptor signaling research and chronic pain research.

• Protease Inhibitor Cocktail for Plant Assays

  2026-08-13

  Preserve labile plant proteins, phosphoproteins, and protein complexes with an EDTA-free inhibitor blend designed for extract-based workflows. This guide connects practical sample handling with the STOP1–STAR1 aluminum-resistance study, showing how better protein preservation can improve Western blot, co-immunoprecipitation, and mechanistic validation.

• Resazurin Cell Viability Assay Kit in Redox Biology

  2026-08-13

  Explore how the Resazurin Cell Viability Assay Kit converts cellular redox activity into actionable viability data. This guide connects assay design with the ROS-driven apoptosis findings reported in lymphoid malignancy research.

• HyperScribe™ Poly (A) Tailing Kit for mRNA Rescue

  2026-08-12

  Convert T7-generated RNA into a more translation-ready template for controlled transfection and micro-injection studies. The workflow is especially useful for testing wild-type versus mutant rescue constructs, where matched RNA integrity, polyadenylation, and delivery conditions are essential for interpretable results.

• GSK2606414: A Causal Map of ER Stress Signaling

  2026-08-12

  GSK2606414 is a selective PERK inhibitor for resolving how ER stress becomes inflammatory cell death. This article translates recent nucleus pulposus cell findings into a practical, causality-focused assay strategy for ER stress research and pathway validation.

• Arachidonic Acid: From Lipids to Stroke Translation

  2026-08-11

  A mechanistic and translational framework for using Arachidonic Acid to interrogate eicosanoid signaling, neuroinflammation, blood-brain barrier injury, and ischemia-reperfusion models—while distinguishing established evidence from testable hypotheses.

445 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page